Biochemical assessment of metabolic associated fatty liver disease
Metabolic-associated fatty liver disease (MAFLD) is defined as fat accumulation in the liver in the presence of metabolic alterations. This disorder is generally asymptomatic and may progress to severe liver disease, which are linked to inflammation and/or fibrosis. MAFLD has a high prevalence (26%)...
Saved in:
Main Authors: | Guerra-Ruiz Armando R., Casals Gregori, Iruzubieta Paula, Lalana Marta, Leis Alba, López Rosa María, Crespo Javier, Morales-Ruiz Manuel |
---|---|
Format: | article |
Language: | EN ES |
Published: |
De Gruyter
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/4e33d0f9576b45d187bf542aad328304 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of oxidative stress and glutathione system in the pathogenesis of nonalcoholic fatty liver disease
by: T. E. Promenasheva, et al.
Published: (2014) -
Autophagy: a new target for nonalcoholic fatty liver disease therapy
by: Mao YQ, et al.
Published: (2016) -
Measurement and clinical usefulness of bilirubin in liver disease
by: Guerra Ruiz Armando Raúl, et al.
Published: (2021) -
Ultrasound Sample Entropy Imaging: A New Approach for Evaluating Hepatic Steatosis and Fibrosis
by: Hsien-Jung Chan, et al.
Published: (2021) -
Valoración bioquímica en la enfermedad hepática grasa asociada a la disfunción metabólica
by: Guerra-Ruiz Armando R., et al.
Published: (2021)